These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35918708)

  • 21. Phenotypic changes of the mesangium in diabetic nephropathy.
    Makino H; Kashihara N; Sugiyama H; Kanao K; Sekikawa T; Shikata K; Nagai R; Ota Z
    J Diabetes Complications; 1995; 9(4):282-4. PubMed ID: 8573747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glomerular extracellular matrices in rat diabetic glomerulopathy by scanning electron microscopy.
    Makino H; Yamasaki Y; Hironaka K; Ota Z
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(1):19-24. PubMed ID: 1352071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Store-Operated Ca2+ Channels in Mesangial Cells Inhibit Matrix Protein Expression.
    Wu P; Wang Y; Davis ME; Zuckerman JE; Chaudhari S; Begg M; Ma R
    J Am Soc Nephrol; 2015 Nov; 26(11):2691-702. PubMed ID: 25788524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in the gene expression programs of renal mesangial cells during diabetic nephropathy.
    Brunskill EW; Potter SS
    BMC Nephrol; 2012 Jul; 13():70. PubMed ID: 22839765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
    Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
    Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isoliquiritigenin entails blockade of TGF-beta1-SMAD signaling for retarding high glucose-induced mesangial matrix accumulation.
    Li J; Kang SW; Kim JL; Sung HY; Kwun IS; Kang YH
    J Agric Food Chem; 2010 Mar; 58(5):3205-12. PubMed ID: 20146476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells.
    Ayo SH; Radnik RA; Garoni JA; Glass WF; Kreisberg JI
    Am J Pathol; 1990 Jun; 136(6):1339-48. PubMed ID: 2356864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Augmentation of kidney injury by basic fibroblast growth factor or platelet-derived growth factor does not induce progressive diabetic nephropathy in the Goto Kakizaki model of non-insulin-dependent diabetes.
    Riley SG; Steadman R; Williams JD; Floege J; Phillips AO
    J Lab Clin Med; 1999 Sep; 134(3):304-12. PubMed ID: 10482316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of intrarenal product TNF-alpha in the development of glomerular and tubulointerstitial tissues changes in elderly patients with diabetic nephropathy].
    Rakitianskaia IA; Riabov SI; Azanchevskaia SV; Riabova TS; Al-Barbari K; Gurkov AS; Popova VB
    Adv Gerontol; 2013; 26(4):658-65. PubMed ID: 24738256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular biology of diabetic glomerulosclerosis.
    Del Prete D; Anglani F; Ceol M; D'Angelo A; Forino M; Vianello D; Baggio B; Gambaro G
    Nephrol Dial Transplant; 1998; 13 Suppl 8():20-5. PubMed ID: 9870421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Highly bioavailable berberine formulation ameliorates diabetic nephropathy through the inhibition of glomerular mesangial matrix expansion and the activation of autophagy.
    Zhang M; Zhang Y; Xiao D; Zhang J; Wang X; Guan F; Zhang M; Chen L
    Eur J Pharmacol; 2020 Apr; 873():172955. PubMed ID: 32001218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation.
    Zhang C; Zhu X; Li L; Ma T; Shi M; Yang Y; Fan Q
    Diabetes Metab Syndr Obes; 2019; 12():1297-1309. PubMed ID: 31447572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydrogen sulfide alleviates diabetic nephropathy in a streptozotocin-induced diabetic rat model.
    Zhou X; Feng Y; Zhan Z; Chen J
    J Biol Chem; 2014 Oct; 289(42):28827-34. PubMed ID: 25164822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetic kidney disease in the db/db mouse.
    Sharma K; McCue P; Dunn SR
    Am J Physiol Renal Physiol; 2003 Jun; 284(6):F1138-44. PubMed ID: 12736165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glomerular expression of platelet-derived growth factor (PDGF)-A, -B chain and PDGF receptor-alpha, -beta in human diabetic nephropathy.
    Uehara G; Suzuki D; Toyoda M; Umezono T; Sakai H
    Clin Exp Nephrol; 2004 Mar; 8(1):36-42. PubMed ID: 15067514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural involvement in type 1 and type 2 diabetic nephropathy.
    Dalla Vestra M; Saller A; Bortoloso E; Mauer M; Fioretto P
    Diabetes Metab; 2000 Jul; 26 Suppl 4():8-14. PubMed ID: 10922968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating fibronectin contributes to mesangial expansion in a murine model of type 1 diabetes.
    Klemis V; Ghura H; Federico G; Würfel C; Bentmann A; Gretz N; Miyazaki T; Gröne HJ; Nakchbandi IA
    Kidney Int; 2017 Jun; 91(6):1374-1385. PubMed ID: 28159318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice.
    Zhang H; Schin M; Saha J; Burke K; Holzman LB; Filipiak W; Saunders T; Xiang M; Heilig CW; Brosius FC
    Am J Physiol Renal Physiol; 2010 Jul; 299(1):F91-8. PubMed ID: 20375116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats.
    Samnegård B; Jacobson SH; Jaremko G; Johansson BL; Ekberg K; Isaksson B; Eriksson L; Wahren J; Sjöquist M
    Nephrol Dial Transplant; 2005 Mar; 20(3):532-8. PubMed ID: 15665028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In situ hybridization studies of matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-1 and type IV collagen in diabetic nephropathy.
    Suzuki D; Miyazaki M; Jinde K; Koji T; Yagame M; Endoh M; Nomoto Y; Sakai H
    Kidney Int; 1997 Jul; 52(1):111-9. PubMed ID: 9211353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.